Nebulizer Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: July 26, 2023 Report Code: GDME1582EPD-ST

Select Item

Nebulizer Systems Pipeline Market Overview

Nebulizer is a device which helps in direct delivery of medicine in case of respiratory disorders. The Nebulizer Systems pipeline market research report provides comprehensive information about the pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories ·       United States

·       Europe

·       China

·       Australia

·       Canada

·       Israel

·       New Zealand

·       United Kingdom
Key Regulatory Paths ·       510(k)

·       CE

·       NMPA

·       TGA

·       MDL
Leading Companies ·       Ablynx NV

·       Aeon Research & Technology

·       Aerami Therapeutics Inc

·       AFT Pharmaceuticals Ltd

·       Baby’s Breath Ltd

·       Breath Therapeutics Holding BV
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Nebulizer Systems Pipeline Market Segmentation by Territories

Some of the key territories in the Nebulizer Systems market are the US, Europe, China, Australia, Canada, Israel, New Zealand, and the UK. As of July 2023, the US had the highest number of pipeline products.

Nebulizer Systems Pipeline Market Analysis by Territories, 2023 (%)

Nebulizer Systems Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the Nebulizer Systems pipeline market, download a free report sample

Nebulizer Systems Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Nebulizer Systems pipeline market are 510(k), CE, NMPA, TGA and MDL. As of July 2023, 510(k) was the most followed pathway for nebulizer systems pipeline products.

Nebulizer Systems Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Nebulizer Systems Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Nebulizer Systems pipeline market, download a free report sample

Nebulizer Systems Pipeline Market – Competitive Landscape

Some of the key companies in the Nebulizer Systems pipeline market are Ablynx NV, Aeon Research & Technology, Aerami Therapeutics Inc, AFT Pharmaceuticals Ltd , Baby’s Breath Ltd, and Breath Therapeutics Holding BV among others.

Ablynx NV: Ablynx, a subsidiary of Sanofi, is a biopharmaceutical company that focuses on developing Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. The company has a portfolio of Nanobody-based therapeutic programs in various vital disease areas, including inflammation, hematology, immuno-oncology and oncology. The company has research collaborations and significant partnerships with key pharmaceutical companies including Merck, Novartis and Boehringer Ingelheim. Ablynx is headquartered in Ghent, Belgium.

Aeon Research & Technology (ART): ART is a medical device manufacturing company that designs, manufactures, develops, and markets medical implants and instruments. It is headquartered in Loves Park, Illinois, the US.

Leading Nebulizer Systems Companies, 2023

Leading Nebulizer Systems Companies, 2023

For more company insights into the Nebulizer Systems pipeline market, download a free report sample

Nebulizer Systems Pipeline Market Segments

Nebulizer Systems Pipeline Market Territories Outlook

  • United States
  • Europe
  • China
  • Australia
  • Canada
  • Israel
  • New Zealand
  • United Kingdom

Nebulizer Systems Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • MDL

Scope

This report provides:

  • Extensive coverage of the Nebulizer Systems under development.

  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.

  • Reviews of the major players involved in the development of Nebulizer Systems and lists of all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.

  • Key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of Nebulizer Systems under development.

  • Develop market-entry and market expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Ablynx NV
Aeon Research & Technology
Aerami Therapeutics Inc
AFT Pharmaceuticals Ltd
Baby's Breath Ltd
Breath Therapeutics Holding BV
Bridgesource Medical Corp
Creare LLC
DesignWise Medical Inc (Inactive)
HCmed Innovations Co Ltd
Marquette University
Monash University
Nob Hill Therapeutics Inc
Omron Healthcare Co Ltd
Omron Healthcare Inc
PARI GmbH
Parion Sciences Inc
Pharmosa Biopharm Inc
Respira Technologies Inc
RMIT University
SolAeroMed Inc
Stirling Pharma Inc
Suzhou Wulian Medical Technology Co Ltd
Teleflex Inc
University of California San Diego
University of Texas Medical Branch at Galveston
Vectura Group Plc
Veoli Ltd
Verona Pharma Plc
Vincent Medical Holdings Ltd
Wellfully Ltd
Wellinks Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 8

2 Introduction 9

2.1 Nebulizer Systems Overview 9

3 Products under Development 10

3.1 Nebulizer Systems – Pipeline Products by Stage of Development 10

3.2 Nebulizer Systems – Pipeline Products by Territory 11

3.3 Nebulizer Systems – Pipeline Products by Regulatory Path 12

3.4 Nebulizer Systems – Pipeline Products by Estimated Approval Date 13

3.5 Nebulizer Systems – Ongoing Clinical Trials 14

4 Nebulizer Systems – Pipeline Products under Development by Companies 15

4.1 Nebulizer Systems Companies – Pipeline Products by Stage of Development 15

4.2 Nebulizer Systems – Pipeline Products by Stage of Development 17

5 Nebulizer Systems Companies and Product Overview 18

5.1 Ablynx NV Company Overview 18

5.1.1 Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 Aeon Research & Technology Company Overview 19

5.2.1 Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Aerami Therapeutics Inc Company Overview 20

5.3.1 Aerami Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 AFT Pharmaceuticals Ltd Company Overview 21

5.4.1 AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Baby’s Breath Ltd Company Overview 24

5.5.1 Baby’s Breath Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.6 Breath Therapeutics Holding BV Company Overview 25

5.6.1 Breath Therapeutics Holding BV Pipeline Products & Ongoing Clinical Trials Overview 25

5.7 Bridgesource Medical Corp Company Overview 29

5.7.1 Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Creare LLC Company Overview 30

5.8.1 Creare LLC Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 DesignWise Medical Inc (Inactive) Company Overview 31

5.9.1 DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 HCmed Innovations Co Ltd Company Overview 32

5.10.1 HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Marquette University Company Overview 33

5.11.1 Marquette University Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 Monash University Company Overview 34

5.12.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 34

5.13 Nob Hill Therapeutics Inc Company Overview 35

5.13.1 Nob Hill Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.14 Omron Healthcare Co Ltd Company Overview 36

5.14.1 Omron Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.15 Omron Healthcare Inc Company Overview 37

5.15.1 Omron Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.16 PARI GmbH Company Overview 38

5.16.1 PARI GmbH Pipeline Products & Ongoing Clinical Trials Overview 38

5.17 Parion Sciences Inc Company Overview 39

5.17.1 Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.18 Pharmosa Biopharm Inc Company Overview 40

5.18.1 Pharmosa Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.19 Respira Technologies Inc Company Overview 44

5.19.1 Respira Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.20 RMIT University Company Overview 45

5.20.1 RMIT University Pipeline Products & Ongoing Clinical Trials Overview 45

5.21 SolAeroMed Inc Company Overview 46

5.21.1 SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.22 Stirling Pharma Inc Company Overview 47

5.22.1 Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.23 Suzhou Wulian Medical Technology Co Ltd Company Overview 48

5.23.1 Suzhou Wulian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.24 Teleflex Inc Company Overview 49

5.24.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.25 University of California San Diego Company Overview 50

5.25.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 50

5.26 University of Texas Medical Branch at Galveston Company Overview 51

5.26.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 51

5.27 Vectura Group Plc Company Overview 52

5.27.1 Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview 52

5.28 Veoli Ltd Company Overview 57

5.28.1 Veoli Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

5.29 Verona Pharma Plc Company Overview 58

5.29.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 58

5.30 Vincent Medical Holdings Ltd Company Overview 60

5.30.1 Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.31 Wellfully Ltd Company Overview 61

5.31.1 Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

5.32 Wellinks Inc Company Overview 62

5.32.1 Wellinks Inc Pipeline Products & Ongoing Clinical Trials Overview 62

6 Appendix 65

6.1 Methodology 65

6.2 About GlobalData 68

6.3 Contact Us 68

6.4 Disclaimer 68

Table

Nebulizer Systems – Pipeline Products by Stage of Development 10

Nebulizer Systems – Pipeline Products by Territory 11

Nebulizer Systems – Pipeline Products by Regulatory Path 12

Nebulizer Systems – Pipeline Products by Estimated Approval Date 13

Nebulizer Systems – Ongoing Clinical Trials 14

Nebulizer Systems Companies – Pipeline Products by Stage of Development 15

Nebulizer Systems – Pipeline Products by Stage of Development 17

Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 18

Customised Infant Inhalation Device – Product Status 18

Customised Infant Inhalation Device – Product Description 18

Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview 19

LYNX Nebulizer – Product Status 19

LYNX Nebulizer – Product Description 19

Aerami Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20

FOX Mesh Nebulizer – Product Status 20

FOX Mesh Nebulizer – Product Description 20

AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

NasoSURF – Product Status 21

NasoSURF – Product Description 21

AFT Pharmaceuticals Ltd – Ongoing Clinical Trials Overview 22

NasoSURF – Pharmacokinetics and Pharmacodynamics of Midazolam Administered Intranasally Using the Nasosurf Device to Healthy Volunteers 23

Baby’s Breath Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

WiseAir – Product Status 24

WiseAir – Product Description 24

Breath Therapeutics Holding BV Pipeline Products & Ongoing Clinical Trials Overview 25

Lung-Targeted BOS Device – Product Status 25

Lung-Targeted BOS Device – Product Description 25

Breath Therapeutics Holding BV – Ongoing Clinical Trials Overview 26

Lung-Targeted BOS Device – A Phase IIa Multi-center, Randomized, Single-blind Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation 27

Lung-Targeted BOS Device – A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Double Lung Transplant 27

Lung-Targeted BOS Device – A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Single Lung Transplant 27

Lung-Targeted BOS Device – A Phase III, Extension Clinical Trial to Demonstrate Efficacy and Safety of Liposomal Cyclosprine A Via the PARI Investigational eFlow Device and SoC in Treating Bronchiolitis Obliterans in Patients Post Single or Double Lung Transplant 28

Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 29

Breath-Adaptive Nebulizer – Product Status 29

Breath-Adaptive Nebulizer – Product Description 29

Creare LLC Pipeline Products & Ongoing Clinical Trials Overview 30

DDC-Based Nebulizer – Product Status 30

DDC-Based Nebulizer – Product Description 30

DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31

Self-Contained Nebulizer System – Product Status 31

Self-Contained Nebulizer System – Product Description 31

HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

AdheResp – Product Status 32

AdheResp – Product Description 32

Marquette University Pipeline Products & Ongoing Clinical Trials Overview 33

Human Powered Nebulizer – Product Status 33

Human Powered Nebulizer – Product Description 33

Monash University Pipeline Products & Ongoing Clinical Trials Overview 34

Nebuliser – Product Status 34

Nebuliser – Product Description 34

Nob Hill Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 35

DryNeb – Product Status 35

DryNeb – Product Description 35

Omron Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Avt – Product Status 36

Avt – Product Description 36

Omron Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Neko Cat – Product Status 37

Neko Cat – Product Description 37

PARI GmbH Pipeline Products & Ongoing Clinical Trials Overview 38

Vibrating Mesh Nebulizer For RespiraClear – Product Status 38

Vibrating Mesh Nebulizer For RespiraClear – Product Description 38

Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 39

tPAD Device – Product Status 39

tPAD Device – Product Description 39

Pharmosa Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview 40

L606 Inhalation System – Product Status 40

L606 Inhalation System – Product Description 40

L608 Inhalation System – Product Status 41

L608 Inhalation System – Product Description 41

Pharmosa Biopharm Inc – Ongoing Clinical Trials Overview 42

L606 Inhalation System – A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety and Tolerability of Liposomal Treprostinil Inhalation Suspension (L606) in Subjects With Pulmonary Arterial Hypertension or Pulmonary Hypertension Associated With Interstitial Lung Disease 43

Respira Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44

RespiRx – Nicotine Replacement Therapy (NRT) – Product Status 44

RespiRx – Nicotine Replacement Therapy (NRT) – Product Description 44

RMIT University Pipeline Products & Ongoing Clinical Trials Overview 45

UAS Nebulizer – Product Status 45

UAS Nebulizer – Product Description 45

SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview 46

S1226 Neublizer System – Product Status 46

S1226 Neublizer System – Product Description 46

Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 47

High Density Aerosol Drug Delivery Device – Product Status 47

High Density Aerosol Drug Delivery Device – Product Description 47

Suzhou Wulian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Nebulization Drug Delivery Device – Product Status 48

Nebulization Drug Delivery Device – Product Description 48

Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Turbomist – Product Status 49

Turbomist – Product Description 49

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 50

Nebulizer – Product Status 50

Nebulizer – Product Description 50

University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 51

Pulse Drug Nebulization System – Product Status 51

Pulse Drug Nebulization System – Product Description 51

Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview 52

FOX Vibrating Mesh Nebulizer – Product Status 52

FOX Vibrating Mesh Nebulizer – Product Description 52

VR475 Combination Device – Product Status 53

VR475 Combination Device – Product Description 53

VR647 – Product Status 53

VR647 – Product Description 54

Vectura Group Plc – Ongoing Clinical Trials Overview 55

VR647 – A Phase I Clinical Study of VR-647 56

VR647 – A Phase I Clinical Study of VR-647 in Adult Asthma Subjects 56

VR647 – Phase II Pharmacokinetic Study of VR-647 in Children 56

VR647 – Phase III Study of VR-647 56

Veoli Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

Cannabis Inhaler Device – Product Status 57

Cannabis Inhaler Device – Product Description 57

Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 58

Ensifentrine + LAMA Nebulizer – Product Status 58

Ensifentrine + LAMA Nebulizer – Product Description 58

RPL554 Nebulizer – Product Status 59

RPL554 Nebulizer – Product Description 59

Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Home Use Ultrasonic Nebulizer – Product Status 60

Home Use Ultrasonic Nebulizer – Product Description 60

Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

Nebulizer – Product Status 61

Nebulizer – Product Description 61

Wellinks Inc Pipeline Products & Ongoing Clinical Trials Overview 62

Bluetooth Enabled Flyp Nebulizer – Product Status 62

Bluetooth Enabled Flyp Nebulizer – Product Description 62

Wellinks Inc – Ongoing Clinical Trials Overview 63

Bluetooth Enabled Flyp Nebulizer – POWER: Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions 64

Glossary 67

Figures

Nebulizer Systems – Pipeline Products by Stage of Development 10

Nebulizer Systems – Pipeline Products by Territory 11

Nebulizer Systems – Pipeline Products by Regulatory Path 12

Nebulizer Systems – Pipeline Products by Estimated Approval Date 13

Nebulizer Systems – Ongoing Clinical Trials 14

Frequently asked questions

Nebulizer Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Nebulizer Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Nebulizer Systems reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Nebulizer Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Nebulizer Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more